Journal News

From the journals: MCP

Kian Kamgar-Parsi
Feb. 18, 2021

Turning to sugars to detect cancer. Creating a new tool to understand protein modification. Finding out how a multimer behaves in sepsis. Read about recent papers on these topics in the journal Molecular & Cellular Proteomics.

Turning to sugars to help detect pancreatic cancer

With nearly 50,000 deaths each year in the U.S. and only a 9% five-year survival rate, pancreatic cancer has one of the worst prognoses of all cancers. At the heart of this is the difficulty in detecting pancreatic cancer early; most patients are diagnosed after the disease is already advanced. The carbohydrate-associated molecules CA19-9 and sTRA have shown value in tracking disease progression but cannot be used to identify pancreatic cancer early or specifically, highlighting the need for other biomarkers.

Recently, researchers have found that, while historically understudied, the coating of carbohydrates on the surface of cells (called the glycocalyx), and particularly a family of these carbohydrates called N-glycans, are associated with pancreatic cancer. New data from Colin McDowell and collaborators at the Medical University of South Carolina and the Van Andel Research Institute, published in Molecular & Cellular Proteomics, provide early insights into the promise of these N-glycans as a potential new biomarker. McDowell and his colleagues used mass spectrometry to detect and differentiate N-glycans. Their research shows that N-glycans have increases in several modifications, including sialylation, poly-LacNAc extensions and branching, that vary in healthy, necrotic and tumor tissue.

The range and complexity of N-glycan modifications likely will preclude any one species from serving as a definitive biomarker of pancreatic cancer; an N-glycan signature is likely the key. The current study also is limited, with some N-glycan species too large to be identified. Despite these drawbacks, the complementarity of this N-glycan evaluation to CA19-9 and sTRA evaluations could improve confidence in tumor detection. The researchers are working to characterize further the role of N-glycans in pancreatic cancer. With an increased understanding of their relation to tumor formation, N-glycans could provide an important diagnostic tool in improving pancreatic cancer detection and, ultimately, saving lives.

FTJ-MCP-Pancreatic-cancer-890x500.jpg
Scientific Animations Inc./Wikimedia
With pancreatic cancer a leading cause of death and hard to detect, an acute need exists for better early biomarkers of disease.

 

"Shepherd" guides understanding of protein modification

While the role of proteins in biology is quite familiar, scientists know less about the importance of post-translational modifications, or PTMs. These PTMs involve the addition of different molecular groups to the protein amino acid chain and are crucial for protein function. However, with 20 types of amino acids and dozens of PTMs, identifying PTMs in complex mixtures remains a major scientific challenge.

Open searching, a methodology to identify PTMs in complex mixtures without prior knowledge of which may be present, is a valuable approach in proteomics. Daniel Geiszler and a team from the University of Michigan have developed a new tool, PTM-Shepherd, to optimize and improve on this methodology.

As described in a paper published in Molecular & Cellular Proteomics, PTM-Shepherd was able to use small protein mass shifts detected by mass spectrometry to identify PTMs, distinguishing modifications differing in mass by as little as 1/400th of a carbon atom. Using the PTM-Shepherd tool, researchers could identify artifacts in protein synthesis and detect differences in presumably identical proteins based on the source lab. PTM-Shepherd could be a strong new tool both for protein synthesis quality control and for identifying rare/novel PTMs in biological research.

 

A proteomic evaluation of PTX3 behavior in sepsis

Sepsis is a deadly condition brought on in response to infection, with 270,000 yearly deaths associated with the complication in the United States alone. Researchers have found that formation of pentraxin-related protein PTX3 multimers (particles composed of multiple copies of a single PTX3 protein) is associated with mortality in sepsis; however, they do not understand fully yet how these multimers are formed. Now new research by Sean Burnap at King's College London and an international team provides novel insights into the role of PTX3 in sepsis.

As published in Molecular & Cellular Proteomics, human and mouse models along with mass spectrometry were used to interrogate the effect of lipopolysaccharide, or LPS (an endotoxin that can cause sepsis), on PTX3 behavior. As expected, higher levels of PTX3 multimers were seen after introduction of LPS, with this increase correlating with increases in proteins derived from neutrophils (white blood cells). In fact, mice without key neutrophil enzymes still showed an increase in PTX3 multimers in response to LPS. Instead of being synthesized in response to LPS, PTX3 multimers appear to be stored in neutrophils and deposited on aortic vessel walls. This improved understanding of PTX3 behavior could provide insights toward development of new treatments for acute sepsis.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Kian Kamgar-Parsi

Kian Kamgar-Parsi received a Ph.D. in biophysics from the University of Michigan and works as a consultant for the pharmaceutical industry.
 

Related articles

From the journals: MCP
Nivedita Uday Hegdekar
From the journals: MCP
Courtney Chandler
From the journals: MCP
Nivedita Uday Hegdekar
From the journals: MCP
Vanshika Patel
From the journals: MCP
Krishnakoli Adhikary
From the journals: MCP
Sephra Rampersad

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

From the journals: JLR
Journal News

From the journals: JLR

Dec. 13, 2024

Fixation method to quantify brain metabolites. Belly fat and liver disease crosstalk. Stopping heart diseases in schizophrenic patients. Read about the recent JLR papers on these topics.

Does a protein hold the key to Alzheimer’s?
Journal News

Does a protein hold the key to Alzheimer’s?

Dec. 10, 2024

Researchers in Maryland and Massachusetts team up to study how SORL1 promotes tau trafficking and seeding in cells that leads to the neurodegenerative disorder.

Cracking the recipe for perfect plant-based eggs
News

Cracking the recipe for perfect plant-based eggs

Dec. 8, 2024

It involves finding just the right proteins. With new ingredients and processes, the next generation of substitutes will be not just more egg-like, but potentially more nutritious.

MSU researchers leverage cryo-EM for decades-in-the-making breakthrough
News

MSU researchers leverage cryo-EM for decades-in-the-making breakthrough

Dec. 7, 2024

Lee Kroos and Ben Orlando have reported the first high-resolution experimentally determined structures of the intramembrane protease SpolVFB.

From the Journals: MCP
Journal News

From the Journals: MCP

Dec. 6, 2024

Rapid and precise SARS-CoV-2 detection using mass spec. Mapping brain changes from drug addiction. Decoding plant osmotic stress response. Read about recent MCP papers on these topics.

What seems dead may not be dead
Award

What seems dead may not be dead

Dec. 4, 2024

Vincent Tagliabracci will receive the Earl and Thressa Stadtman Distinguished Scientist Award at the ASBMB Annual Meeting, April 12–15 in Chicago.